Yi Xiao

Children's Medical Center — United States

Medicine · Health Sciences

29h-index3.8kcitations120works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(26), Ferroptosis and cancer prognosis(16), RNA modifications and cancer(10), Cancer Genomics and Diagnostics(8), Glutathione Transferases and Polymorphisms(8)

Publications120 total

Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial)
Molecular Cancer·2025Open Access
Challenges and opportunities for cardiac organoids: A comprehensive review
Regenesis repair rehabilitation.·2025Open Access
Collateral metabolic vulnerabilities unveiled by loss of isozyme diversity in breast cancer
Genome Medicine·2025Open Access
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
UNC Libraries·2025Open Access
A metabolic comparison of <scp>GIPR</scp> agonism versus <scp>GIPR</scp> antagonism in male mice
Diabetes Obesity and Metabolism·2025Open Access
Author response for "A metabolic comparison of GIPR agonism vs GIPR antagonism in male mice"
2025
Berberine overcomes paclitaxel resistance in triple-negative breast cancer by inhibiting HSP90-mediated BRCA1 phosphorylation
Experimental Cell Research·2025
Knowledge, Attitudes, and Practices of Lower Limb Arteriosclerosis Obliterans among Patients: A Latent Profile Analysis
Annals of Vascular Surgery·2025
TMET-32. Cell-intrinsic pyrimidine synthesis pathway choice in human brain and glioma
Neuro-Oncology·2025Open Access
TMET-27. Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesis
Neuro-Oncology·2025Open Access
TMOD-12. Preclinical and clinical assessment of chemoradiation after mutant IDH inhibitor treatment in IDH-mutant glioma
Neuro-Oncology·2025Open Access
TMET-34. A Targetable Metabolic Signal Drives Neuronal Hyperexcitability and Glioma Aggressiveness
Neuro-Oncology·2025Open Access
Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment
Neuro-Oncology·2025· 2 citedOpen Access
Author response for "A metabolic comparison of GIPR agonism vs GIPR antagonism in male mice"
2025
P12.22.A A GENETIC MOUSE MODEL OF IDH-MUTANT GLIOMA RESPONDS TO MUTANT IDH INHIBITION AND REVEALS ENHANCED EFFICACY OF SALVAGE CHEMORADIATION AFTER VORASIDENIB
Neuro-Oncology·2025Open Access
Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growth
2025Open Access
Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesis
2025· 1 citedOpen Access
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice
2025· 1 citedOpen Access
0912 Dupilumab unmasking cutaneous γδ T cell lymphoma through promoting tumorous T cell aggressiveness and microenvironment reprogramming
Journal of Investigative Dermatology·2025· 1 cited
Osthole attenuates airway inflammation in asthma by inhibiting the HMGB1–RAGE/TLR4–NF-κB signaling pathway
Cytotechnology·2025
page 1 of 6Next →

Frequent Co-authors

Yi‐Zhou Jiang(7), F. Peter Guengerich(7), David Meierhofer(6), Zhi‐Ming Shao(5), Milan R. Savani(5), Samuel K. McBrayer(5), Ding Ma(4), Shen Zhao(4), Diana D. Shi(4), Lauren C. Gattie(4), Lauren G. Zacharias(4), Thomas P. Mathews(4), Timothy E. Richardson(4), Kalil G. Abdullah(4), Jonas Busch(4), Ergin Kilic(4), Klaus Jung(4), Jinxiu Shi(3), Claire F. Verschraegen(3), Virginia Kaklamani(3)